Product name: Furazabol THP
Other name: 17-hydroxy-5-androstano-2,3-c]furazan 17-THP ether; 5a-androstano(2,3-c) furazan-17b-tetrahydropyranol ether
CAS register number: 1239-29-8
EINECS number: 214-983-0
Molecular formula: C20H30N2O2
Molecular weight: 330.46
Appearance: White powder
Furazabol THP description
Furazabol (Miotolan) is a derivative of anabolic steroid alcohols. By using the furazan ring instead of pyrazole, it is different from the amidazole. It has a c-17alpha methyl which allows it to be oral, causing some personal hepatotoxicity.
Furazabol THP application
Furazabol cholesterol is mythical. In the 1970s, studies have shown that furazabol with many other oral active AAS (such as Anavar (oxandrolone)) reduces total serum cholesterol. The subsequent determination of cholesterol reduction in oral AAS was the result of a decrease in HDL levels. Thus, it is expected that, as with other oral metabolic steroids, furartabol lowering total cholesterol levels will adversely affect the HDL / LDL ratio and increase the risk of cardiovascular disease.
Furazabol THP usage
Treatment of hyperlipidemia and atherosclerosis have the ability to regulate blood lipids, liver cholesterol can promote acid decomposition, discharge of cholesterol to reduce the role; can inhibit the release of fatty acids from adipose tissue into the liver, reduce free fatty liver acid content decreased, liver triglycerides Reduce, thereby reducing blood levels of triglycerides. Synthesis of metabolism, promote and inhibit protein metabolism, increase appetite, enhance physical fitness, promote growth and development and promote tissue regeneration.
Furazabol THP dose
The effective dose of Miotolan appears to start in the range of 10-20 mg per day for men taking no more than 6 or 8 weeks. At this level, it seems to be given a measurable muscle manufacturing effect, usually accompanied by a reduction in fat.
A daily dose of 30 mg or more significantly increases the synthetic metabolic potential of the drug, but at the expense of higher hepatotoxicity (from Llewellyn). In particular, some applications have reported higher yields of good doses of 100 mg to 300 mg per day (see reference line).
For females, the effective dose is 2-5 mg per day, 4-6 weeks cycle.
Furazabol THP Application and function
Furazabol Thp has a half-life of only four hours, which means that it needs to be sustained to maintain adequate, effective levels in the body.
The role of furazabol Thp is similar to that of Winstrol, and the therapeutic dose of Furazabol Thp is said to improve human lipids in addition to adversely affecting cholesterol levels. Therefore, Furazabol Thp in Japan in Japan under the trade name Miotolan in the 20th century began in the 1970s as a hypercholesterolemic treatment. Both and Winstrol are modified dihydrotestosterone (DHT) molecules; the former has the furazan group, the latter is pyrazolyl. This may be a different effect on blood lipids.
Furazabol Thp reduces blood lipids and is used as a standard drug for high cholesterol. It increases the HDL value (good cholesterol) in the same way, lowering the LDL value (bad cholesterol).
Thank you for your donation.